Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06844032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predictors of Poor Prognosis in HFpEF

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 1, 2025 to Dec 31, 2026
    • Enrollment target: 400 to 500
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v3
  2. Study title revised
    • Eligibility criteria shortened, about 2 words
    • Study description expanded, about 2 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients with HFpEF who have undergone meticulous clinical and instrumental evaluation (including diastolic exercise testing) between 2013 and 2020, will be followed up for at least 3 years.
Trial Details
NCT Number NCT06844032
Lead Sponsor National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions
(from sponsor)		 HFpEF
Related terms Hypertrophy, Left Ventricular
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov